Baird raised the firm’s price target on Charles River to $252 from $220 and keeps an Outperform rating on the shares. The firm noted the company did not give any color on Q4 or its 2024 outlook while presenting at a conference and said they didn’t hear anything incremental.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRL:
- Charles River, Vertex reach important milestone in cell therapy collaboration
- Charles River expands 3D in vitro services in agreement with CELLphenomics
- Charles River price target raised by $25 at Citi, here’s why
- Fly Insider: Impinj, Appfolio among week’s notable insider trades
- Charles River, Aita enter strategic agreement